Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $669.72 billion, total revenue of $168.84 billion and a weighted average PE ratio of 38.51.
Market Cap
669.72B
Revenue
168.84B
Profits
17.39B
PE Ratio
38.51
Profit Margin
10.30%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 177.61B | 0.79% | 1,913,151 | 44.56B |
| 2 | DHR | Danaher Corporation | 134.36B | 0.34% | 3,146,341 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 46.06B | 0.22% | 415,742 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 31.66B | 0.65% | 1,975,784 | 7.07B |
| 5 | WAT | Waters Corporation | 29.61B | 0.94% | 962,971 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 28.33B | 0.54% | 1,402,866 | 16.31B |
| 7 | NTRA | Natera, Inc. | 27.95B | 2.46% | 853,814 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.18B | 2.87% | 160,378 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 21.79B | 0.54% | 635,241 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.52B | 0.17% | 881,144 | 11.04B |
| 11 | EXAS | Exact Sciences Corporation | 20.03B | - | - | 3.25B |
| 12 | ILMN | Illumina, Inc. | 18.93B | -0.43% | 1,309,339 | 4.34B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.97B | 0.98% | 250,051 | 2.53B |
| 14 | GH | Guardant Health, Inc. | 11.14B | -0.26% | 1,506,363 | 982.02M |
| 15 | RVTY | Revvity, Inc. | 9.74B | 1.42% | 935,912 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 8.57B | -1.10% | 2,086,784 | 2.09B |
| 17 | CRL | Charles River Laboratories International, Inc. | 7.78B | 2.86% | 984,222 | 4.02B |
| 18 | ICLR | ICON Public Limited Company | 7.66B | 0.65% | 697,409 | 8.10B |
| 19 | RDNT | RadNet, Inc. | 4.79B | 0.41% | 675,788 | 2.04B |
| 20 | SHC | Sotera Health Company | 3.95B | 2.81% | 2,935,517 | 1.16B |
| 21 | BLLN | BillionToOne, Inc. | 3.66B | 4.72% | 268,657 | 305.11M |
| 22 | TWST | Twist Bioscience Corporation | 2.73B | 5.78% | 1,767,136 | 391.56M |
| 23 | VCYT | Veracyte, Inc. | 2.67B | 5.34% | 1,271,250 | 517.15M |
| 24 | WGS | GeneDx Holdings Corp. | 2.11B | 3.29% | 490,567 | 427.54M |
| 25 | GRAL | GRAIL, Inc. | 2.02B | 4.89% | 715,405 | 147.17M |
| 26 | NEO | NeoGenomics, Inc. | 1.05B | 1.76% | 1,539,593 | 727.33M |
| 27 | CDNA | CareDx, Inc. | 899.36M | 2.39% | 616,079 | 379.81M |
| 28 | OPK | OPKO Health, Inc. | 882.86M | 2.68% | 4,480,416 | 606.88M |
| 29 | PSNL | Personalis, Inc. | 796.25M | 4.82% | 2,159,554 | 69.65M |
| 30 | CSTL | Castle Biosciences, Inc. | 765.58M | 3.00% | 161,426 | 344.23M |
| 31 | FLGT | Fulgent Genetics, Inc. | 510.00M | 5.29% | 882,738 | 322.67M |
| 32 | BNR | Burning Rock Biotech Limited | 490.18M | -2.72% | 9,920 | 77.14M |
| 33 | MYGN | Myriad Genetics, Inc. | 435.75M | 1.75% | 2,186,530 | 824.50M |
| 34 | PRE | Prenetics Global Limited | 361.14M | 9.38% | 133,354 | 92.39M |
| 35 | MDXH | MDxHealth SA | 157.90M | 0.95% | 91,108 | 107.88M |
| 36 | BDSX | Biodesix, Inc. | 144.82M | -1.24% | 86,205 | 88.50M |
| 37 | FONR | FONAR Corporation | 120.23M | -0.22% | 38,529 | 106.03M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 115.52M | -5.40% | 115,384 | 4.40M |
| 39 | XGN | Exagen Inc. | 68.55M | 2.52% | 215,111 | 66.58M |
| 40 | PRPO | Precipio, Inc. | 47.18M | -3.41% | 18,403 | 22.80M |
| 41 | BIAF | bioAffinity Technologies, Inc. | 21.28M | 73.26% | 64,365,154 | 6.16M |
| 42 | MBAI | Check-Cap Ltd. | 12.46M | 4.91% | 34,899 | - |
| 43 | NOTV | Inotiv, Inc. | 11.24M | 10.15% | 432,355 | 514.03M |
| 44 | XWEL | XWELL, Inc. | 7.96M | 12.20% | 244,709 | 29.52M |
| 45 | ADVB | Advanced Biomed Inc. | 4.52M | 0.72% | 12,577 | - |
| 46 | NDRA | ENDRA Life Sciences Inc. | 4.06M | 0.87% | 18,799 | - |
| 47 | ISPC | iSpecimen Inc. | 1.76M | -8.06% | 2,077,430 | 3.35M |